Cited by 2,990Neuroinflammation and Neurodegeneration MechanismsParkinson's Disease Mechanisms and TreatmentsAlzheimer's disease research and treatments

The DOI matches its Crossref record.

Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

McGeer, P. L., Itagaki, S., Boyes, B. E., McGeer, E. G.·1988·Neurology

DOI 10.1212/wnl.38.8.1285

Open this paper in CoChat — free account

Abstract

We detected large numbers of HLA-DR-positive reactive microglia (macrophages), along with Lewy bodies and free melanin, in the substantia nigra of all cases studied with Parkinson's disease (5) and parkinsonism with dementia (PD) (5). We found similar, but less extensive, pathology in the substantia nigra of six of nine cases of dementia of the Alzheimer type (DAT) but in only one of 11 age-matched nonneurologic cases. All dementia cases with a premortem diagnosis of DAT or PD showed large numbers of HLA-DR-positive reactive microglia and significant plaque and tangle counts in the hippocampus, as well as reduced cortical choline acetyltransferase activity. One of 11 nondemented controls showed mild evidence of similar cortical pathology. These data indicate that HLA-DR-positive reactive microglia are a sensitive index of neuropathologic activity. They suggest a frequent coexistence of DAT- and Parkinson-type pathology in elderly patients.

Integrity signals

Registry

Crossref · 10.1212/wnl.38.8.1285

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Still being checked.

Sorted by citations

Items 601–700 of 1,040

Hyperbaric oxygen reduces delayed immune-mediated neuropathology in experimental carbon monoxide toxicity
Thom, S. R., Bhopale, V. M., & Fisher, D. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2005.10.006 · Cited by 118
GM-CSF induces neuroprotective and anti-inflammatory responses in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxicated mice
Kosloski, L. M., Kosmacek, E. A., Olson, K. E., Mosley, R. L., & Gendelman, H. E. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.10.009 · Cited by 119
Circulating interleukin-15 and RANTES chemokine in Parkinson’s disease
Rentzos, M., Nikolaou, C., Andreadou, E., Paraskevas, G. P., Rombos, A., Zoga, M., Tsoutsou, A., Boufidou, F., Kapaki, E., & Vassilopoulos, D. (2007) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2007.00894.x · Cited by 123
Activation of microglia induces symptoms of Parkinson’s disease in wild-type, but not in IL-1 knockout mice
Tanaka, S., Ishii, A., Ohtaki, H., Shioda, S., Yoshida, T., & Numazawa, S. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-143 · Cited by 118
Differential expression of miRNA 155 and miRNA 146a in Parkinson's disease patients
Caggiu, E., Paulus, K. S., Mameli, G., Arru, G., Sechi, G., & Sechi, L. A. (2018) · eNeurologicalSci · doi:10.1016/j.ensci.2018.09.002 · Cited by 119
Association of interleukin-1β polymorphisms with idiopathic Parkinson's disease
McGeer, P. L., Yasojima, K., & McGeer, E. G. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00300-2 · Cited by 118
Self-citation
TGF-β1 Represses Activation and Resultant Death of Microglia via Inhibition of Phosphatidylinositol 3-Kinase Activity
Kim, W.-K., Hwang, S.-Y., Oh, E., Piao, H. Z., Kim, K.-W., & Han, I. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.7015 · Cited by 116
Neuronal MHC-I expression and its implications in synaptic function, axonal regeneration and Parkinson’s and other brain diseases
Cebrián, C., Loike, J. D., & Sulzer, D. (2014) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2014.00114 · Cited by 121
Parkinson's disease in the nuclear age of neuroinflammation
Nolan, Y. M., Sullivan, A. M., & Toulouse, A. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.12.003 · Cited by 119
Mechanisms of Altered Redox Regulation in Neurodegenerative Diseases—Focus on S-Glutathionylation
Liedhegner, E. S., Gao, X., & Mieyal, J. J. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4119 · Cited by 118
Kv1.3 modulates neuroinflammation and neurodegeneration in Parkinson’s disease
Sarkar, S., Nguyen, H. M., Malovic, E., Luo, J. D., Langley, M. R., Palanisamy, B. N., Singh, N., Manne, S., Neal, M. P., Gabrielle, M., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci136174 · Cited by 118
Effects of dietary restriction on neuroinflammation in neurodegenerative diseases
Fontana, L., Ghezzi, L., Cross, A. H., & Piccio, L. M. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20190086 · Cited by 119
Endocannabinoids and neurodegenerative diseases
Micale, V., Mazzola, C., & Drago, F. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.09.008 · Cited by 119
Mechanisms and consequences of impaired lipid trafficking in Niemann–Pick type C1-deficient mammalian cells
Karten, B., Peake, K., & Vance, J. E. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.01.025 · Cited by 121
Innate and adaptive immune responses in Parkinson's disease
Schonhoff, A. M., Williams, G. P., Wallen, Z. D., Standaert, D. G., & Harms, A. S. (2019) · Progress in brain research · doi:10.1016/bs.pbr.2019.10.006 · Cited by 119
Lipopolysaccharide animal models of Parkinson’s disease: Recent progress and relevance to clinical disease
Deng, I. B., Corrigan, F., Zhai, G., Zhou, X., & Bobrovskaya, L. (2020) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2020.100060 · Cited by 129
Neurodegeneration by α-synuclein-specific T cells in AAV-A53T-α-synuclein Parkinson’s disease mice
Karikari, A. A., McFleder, R. L., Ribechini, E., Blum, R., Bruttel, V., Knorr, S., Gehmeyr, M., Volkmann, J., Brotchie, J. M., Ahsan, F., et al. (2022) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2022.01.007 · Cited by 116
Differential α-synuclein expression contributes to selective vulnerability of hippocampal neuron subpopulations to fibril-induced toxicity
Luna, E., Decker, S. C., Riddle, D. M., Caputo, A., Zhang, B., Cole, T. A., Caswell, C., Xie, S. X., Lee, V. M. ‐., & Luk, K. C. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1829-8 · Cited by 116
The gamma chain subunit of Fc receptors is required for alpha-synuclein-induced pro-inflammatory signaling in microglia
Cao, S., Standaert, D. G., & Harms, A. S. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-259 · Cited by 115
Lysosome and Inflammatory Defects in GBA1‐Mutant Astrocytes Are Normalized by LRRK2 Inhibition
Sanyal, A., DeAndrade, M. P., Novis, H. S., Lin, S. C., Chang, J., Lengacher, N. A., Tomlinson, J. J., Tansey, M. G., & LaVoie, M. J. (2020) · Movement Disorders · doi:10.1002/mds.27994 · Cited by 111
Brain macrophages: neurotoxic or neurotrophic effector cells?
Mallat, M., & Chamak, B. (1994) · Journal of Leukocyte Biology · doi:10.1002/jlb.56.3.416 · Cited by 114
Innate Inflammation in Parkinson's DiseasePreprint
Perry, V. H. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009373 · Cited by 118
Microglial activation in Parkinson’s disease using [18F]-FEPPA
Ghadery, C., Koshimori, Y., Coakeley, S., Harris, M., Rusjan, P., Kim, J., Houle, S., & Strafella, A. P. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0778-1 · Cited by 113
Further characterisation of the LPS model of Parkinson’s disease: A comparison of intra-nigral and intra-striatal lipopolysaccharide administration on motor function, microgliosis and nigrostriatal neurodegeneration in the rat
Hoban, D. B., Connaughton, E., Connaughton, C., Hogan, G., Thornton, C., Mulcahy, P. J., Moloney, T. C., & Dowd, E. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.10.001 · Cited by 114
Monomeric α-synuclein induces blood–brain barrier dysfunction through activated brain pericytes releasing inflammatory mediators in vitro
Dohgu, S., Takata, F., Matsumoto, J., Kimura, I., Yamauchi, A., & Kataoka, Y. (2019) · Microvascular Research · doi:10.1016/j.mvr.2019.03.005 · Cited by 114
Induction of immune system mediators in the hippocampal formation in Alzheimer's and Parkinson's diseases: Selective effects on specific interleukins and interleukin receptors
Araujo, D. M., & Lapchak, P. A. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90398-0 · Cited by 113
Microglia and myeloperoxidase: A deadly partnership in neurodegenerative disease
Lefkowitz, D. L., & Lefkowitz, S. S. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.05.021 · Cited by 113
Immunologic diseases, anti-inflammatory drugs, and Parkinson disease: A case-control study
Bower, J. H., Maraganore, D. M., Peterson, B. J., Ahlskog, J. E., & Rocca, W. A. (2006) · Neurology · doi:10.1212/01.wnl.0000227906.99570.cc · Cited by 113
MPP + ‐induced COX‐2 activation and subsequent dopaminergic neurodegeneration
Wang, T., Pei, Z., Zhang, W., Liu, B., Langenbach, R. I., Lee, C., Wilson, B. C., Reece, J. M., Miller, D. S., & Hong, J. (2005) · The FASEB Journal · doi:10.1096/fj.04-2457fje · Cited by 113
Differential upregulation of the cannabinoid CB2 receptor in neurotoxic and inflammation-driven rat models of Parkinson's disease
Concannon, R. M., Okine, B. N., Finn, D. P., & Dowd, E. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.04.007 · Cited by 112
Temporal evolution of microglia and α-synuclein accumulation following foetal grafting in Parkinson’s disease
Olanow, C. W., Savolainen, M., Chu, Y., Halliday, G. M., & Kordower, J. H. (2019) · Brain · doi:10.1093/brain/awz104 · Cited by 112
Macrophage/microglial-mediated primary demyelination and motor disease induced by the central nervous system production of interleukin-3 in transgenic mice.
Chiang, C., Powell, H. C., Gold, L. H., Samimi, A., & Campbell, I. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118574 · Cited by 112
Imaging of microglia in patients with neurodegenerative disorders
Politis, M. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00096 · Cited by 111
Regulation of myeloid cell phagocytosis by LRRK2 via WAVE2 complex stabilization is altered in Parkinson’s disease
Kim, K. S., Marcogliese, P. C., Yang, J., Callaghan, S. M., Resende, V., Abdel-Messih, E., Marras, C., Visanji, N. P., Huang, J., Schlossmacher, M. G., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1718946115 · Cited by 111
One-Step Electrochemical Fabrication of Reduced Graphene Oxide/Gold Nanoparticles Nanocomposite-Modified Electrode for Simultaneous Detection of Dopamine, Ascorbic Acid, and Uric Acid
Lee, C., Yu, S., & Kim, T. H. (2017) · Nanomaterials · doi:10.3390/nano8010017 · Cited by 111
Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system
Aymerich, M. S., Aso, E., Abellanas, M. A., Tolón, R. M., Ramos, J. A., Ferrer, I., Romero, J., & Fernández‐Ruíz, J. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.08.016 · Cited by 113
Inhibition of thrombin‐induced microglial activation and NADPH oxidase by minocycline protects dopaminergic neurons in the substantia nigra in vivo
Choi, S. H., Lee, D. Y., Chung, E. S., Hong, Y. B., Kim, S. U., & Jin, B. K. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03503.x · Cited by 112
Absence of MHC class ii molecules reduces CNS demyelination, microglial/macrophage infiltration, and twitching in murine globoid cell leukodystrophy
Matsushima, G. K., Taniike, M., Glimcher, L. H., Grusby, M. J., Frelinger, J. A., Suzuki, K., & Ting, J. P. ‐. (1994) · Cell · doi:10.1016/0092-8674(94)90529-0 · Cited by 111
Parkinson's disease as multifactorial oxidative neurodegeneration: implications for integrative management.
Kidd, P. M. (2000) · PubMed · Cited by 110
Detection of lysosomal cysteine proteinases in microglia: Flow cytometric measurement and histochemical localization of cathepsin B and L
Banati, R. B., Rothe, G., Valet, G., & Kreutzberg, G. W. (1993) · Glia · doi:10.1002/glia.440070208 · Cited by 111
Brain region-specific gene expression profiles in freshly isolated rat microglia
Doorn, K. J., Brevé, J. J. P., Drukarch, B., Boddeke, H. W. G. M., Huitinga, I., Lucassen, P. J., & van Dam, A. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00084 · Cited by 114
Mitoapocynin Treatment Protects Against Neuroinflammation and Dopaminergic Neurodegeneration in a Preclinical Animal Model of Parkinson’s Disease
Ghosh, A., Langley, M. R., Harischandra, D. S., Neal, M. P., Jin, H., Anantharam, V., Joseph, J., Brenza, T. M., Narasimhan, B., Kanthasamy, A., et al. (2016) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-016-9650-4 · Cited by 107
Neurodegeneration and Neuroinflammation in Parkinson’s Disease: a Self-Sustained Loop
Arena, G., Sharma, K., Agyeah, G., Krüger, R., Grünewald, A., & Fitzgerald, J. C. (2022) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-022-01207-5 · Cited by 121
Low levels of astroglial markers in Parkinson’s disease: relationship to α-synuclein accumulation
Tong, J., Ang, L.-C., Williams, B., Furukawa, Y., Fitzmaurice, P. S., Guttman, M., Boileau, I., Hornykiewicz, O., & Kish, S. J. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.06.010 · Cited by 112
Influence of LPS-induced neuroinflammation on acetylcholinesterase activity in rat brain
Tyagi, E., Agrawal, R., Nath, C., & Shukla, R. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.08.015 · Cited by 110
In vivo imaging of neuroinflammation
Cagnin, A. (2002) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(02)00107-4 · Cited by 110
α-Synuclein Vaccination Prevents the Accumulation of Parkinson Disease-Like Pathologic Inclusions in Striatum in Association With Regulatory T Cell Recruitment in a Rat Model
Sánchez-Guajardo, V., Annibali, A., Jensen, P. H., & Romero‐Ramos, M. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31829768d2 · Cited by 110
The function of microglia, either neuroprotection or neurotoxicity, is determined by the equilibrium among factors released from activated microglia in vitro
Li, L., Lu, J., Tay, S. S. W., Moochhala, S., & He, B. P. (2007) · Brain Research · doi:10.1016/j.brainres.2007.04.066 · Cited by 110
Interleukin-10 Protects Lipopolysaccharide-Induced Neurotoxicity in Primary Midbrain Cultures by Inhibiting the Function of NADPH Oxidase
Li, Q., Block, M. L., Wei, S., Lin, C., Reece, J. M., Pang, H., Wilson, B. C., Hong, J., & Flood, P. M. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.106351 · Cited by 110
Reactive microgliosis: extracellular μ-calpain and microglia-mediated dopaminergic neurotoxicity
Levesque, S., Wilson, B. C., Gregoria, V., Thorpe, L. B., Dallas, S., Polikov, V. S., Hong, J., & Block, M. L. (2010) · Brain · doi:10.1093/brain/awp333 · Cited by 112
Delivery of Therapeutic Proteins via Extracellular Vesicles: Review and Potential Treatments for Parkinson’s Disease, Glioma, and Schwannoma
Hall, J. S., Prabhakar, S., Balaj, L., Lai, C. P., Cerione, R. A., & Breakefield, X. O. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0309-0 · Cited by 110
Cellular and molecular pathophysiology in the progression of Parkinson’s disease
Zaman, V., Shields, D. C., Shams, R., Drasites, K. P., Matzelle, D. D., Haque, A., & Banik, N. L. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00689-5 · Cited by 119
Upregulation of Protease-Activated Receptor-1 in Astrocytes in Parkinson Disease: Astrocyte-Mediated Neuroprotection Through Increased Levels of Glutathione Peroxidase
Ishida, Y., Nagai, A., Kobayashi, S., & Kim, S. U. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000195941.48033.eb · Cited by 109
Phagocytosis of ?/A4 amyloid fibrils of the neuritic neocortical plaques
Wisniewski, H. M., Barcikowska, M., & Kida, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00310142 · Cited by 109
Genetic Insights into Sporadic Parkinson's Disease Pathogenesis
Chai, C., & Lim, K. (2014) · Current Genomics · doi:10.2174/1389202914666131210195808 · Cited by 113
Potential Neuroprotective Activity of Ginseng in Parkinson’s Disease: A Review
González‐Burgos, E., Fernández‐Moriano, C., & Gómez-Serranillos, M. P. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-014-9569-6 · Cited by 108
Role of α-synuclein in microglia: autophagy and phagocytosis balance neuroinflammation in Parkinson’s disease
Lv, Q.-K., Tao, K., Wang, X.-B., Yao, X., Pang, M., Liu, J., Wang, F., & Liu, C. (2023) · Inflammation Research · doi:10.1007/s00011-022-01676-x · Cited by 117
γδ+ T cells are increased in patients with Parkinson's disease
Fiszer, U., Mix, E., Fredrikson, S., Kostulas, V., Olsson, T. P., & Link, H. (1994) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)90154-6 · Cited by 108
Reactive Oxygen Species and Inhibitors of Inflammatory Enzymes, NADPH Oxidase, and iNOS in Experimental Models of Parkinson’s Disease
Koppula, S., Kumar, H., Kim, I. S., & Choi, D. (2012) · Mediators of Inflammation · doi:10.1155/2012/823902 · Cited by 109
DJ ‐1 deficiency triggers microglia sensitivity to dopamine toward a pro‐inflammatory phenotype that is attenuated by rasagiline
Trudler, D., Weinreb, O., Mandel, S. A., Youdim, M. B. H., & Frenkel, D. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12633 · Cited by 111
Resident microglia die and infiltrated neutrophils and monocytes become major inflammatory cells in lipopolysaccharide‐injected brain
Ji, K., Yang, M., Jeong, H., Min, K., Kang, S., Jou, I., & Joe, E.-H. (2007) · Glia · doi:10.1002/glia.20571 · Cited by 107
The Endotoxin-Induced Neuroinflammation Model of Parkinson's Disease
Tüfekçi, K. U., Genç, Ş., & Genç, K. (2011) · Parkinson s Disease · doi:10.4061/2011/487450 · Cited by 110
Expression of mutant alpha-synuclein modulates microglial phenotype in vitro
Rojanathammanee, L., Murphy, E. J., & Combs, C. K. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-44 · Cited by 106
Advances in imaging in Parkinson's disease
Stoessl, A. J., Martin, W. R. W., McKeown, M. J., & Sossi, V. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70214-9 · Cited by 106
Inflammation, mitochondria, and the inhibition of adult neurogenesis
Voloboueva, L. A., & Giffard, R. G. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22768 · Cited by 109
Tyrosine hydroxylase (TH), its cofactor tetrahydrobiopterin (BH4), other catecholamine-related enzymes, and their human genes in relation to the drug and gene therapies of Parkinson’s disease (PD): historical overview and future prospects
Nagatsu, T., & Nagatsu, I. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-016-1596-4 · Cited by 109
Hesperetin inhibits neuroinflammation on microglia by suppressing inflammatory cytokines and MAPK pathways
Jo, S. H., Kim, M. E., Cho, J. H., Lee, Y., Lee, J., Park, Y., & Lee, J. S. (2019) · Archives of Pharmacal Research · doi:10.1007/s12272-019-01174-5 · Cited by 106
BMAL1 regulation of microglia‐mediated neuroinflammation in MPTP‐induced Parkinson's disease mouse model
Liu, W., Wei, S., Huang, G., Liu, L.-B., Gu, C., Shen, Y., Wang, X., Xia, S., Xie, A., Hu, L., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201901565rr · Cited by 107
Microglial alterations in human Alzheimer's disease following Aβ42 immunization
Zotova, E., Holmes, C., Johnston, D. A., Neal, J., Nicoll, J. A. R., & Boche, D. (2010) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01156.x · Cited by 109
Pathological dynamics of activated microglia following medial forebrain bundle transection
Cho, B. P., Song, D., Sugama, S., Shin, D. H., Shimizu, Y., Kim, S. S., Kim, Y. S., & JOH, T. H. (2005) · Glia · doi:10.1002/glia.20265 · Cited by 106
Alpha-synuclein activates BV2 microglia dependent on its aggregation state
Hoffmann, A., Ettle, B., Bruno, A., Kulinich, A. O., Hoffmann, A.-C., von Wittgenstein, J., Winkler, J., Xiang, W., & Schlachetzki, J. C. M. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.09.109 · Cited by 111
Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers
Strafella, A. P., Bohnen, N. I., Perlmutter, J. S., Eidelberg, D., Pavese, N., van Eimeren, T., Piccini, P. P., Politis, M., Thobois, S., Ceravolo, R., et al. (2017) · Movement Disorders · doi:10.1002/mds.26907 · Cited by 110
Lipid and immune abnormalities causing age-dependent neurodegeneration and Parkinson’s disease
Hallett, P. J., Engelender, S., & Ole Isacson, A. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1532-2 · Cited by 105
Role of Formyl Peptide Receptor–Like 1 (FPRL1/FPR2) in Mononuclear Phagocyte Responses in Alzheimer Disease
Iribarren, P., Zhou, Y., Hu, J., Le, Y., & Wang, J. M. (2005) · Immunologic Research · doi:10.1385/ir:31:3:165 · Cited by 108
Infusion of iron into the rat substantia nigra: Nigral pathology and dose‐dependent loss of striatal dopaminergic markers
Sengstock, G. J., Olanow, C. W., Menzies, R. A., Dunn, A. J., & Arendash, G. W. (1993) · Journal of Neuroscience Research · doi:10.1002/jnr.490350109 · Cited by 105
The role of the immune system in neurodegenerative disorders: Adaptive or maladaptive?
Doty, K. R., Guillot-Sestier, M.-V., & Town, T. (2015) · Brain Research · doi:10.1016/j.brainres.2014.09.008 · Cited by 104
Microglia-targeting nanotherapeutics for neurodegenerative diseases
Zhao, N., Francis, N. L., Calvelli, H. R., & Moghe, P. V. (2020) · APL Bioengineering · doi:10.1063/5.0013178 · Cited by 104
The impact of glial activation in the aging brain.
Lynch, A. M., Murphy, K. J., Deighan, B. F., O’Reilly, J.-A., Gun’ko, Y. K., Cowley, T. R., González-Reyes, R. E., & Lynch, M. A. (2010) · Europe PMC (PubMed Central) · Cited by 103
α-Synuclein pathology as a target in neurodegenerative diseases
Park, H.-J., Kam, T., Dawson, V. L., & Dawson, T. M. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-01043-w · Cited by 121
Anti-inflammatory effects of catechols in lipopolysaccharide-stimulated microglia cells: Inhibition of microglial neurotoxicity
Zheng, L. T., Ryu, G.-M., Kwon, B., Lee, W., & Suk, K. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.04.035 · Cited by 104
Modulation of Intracellular Formation of Reactive Oxygen Intermediates in Peritoneal Macrophages and Microglia/Brain Macrophages by Propentofylline
Banati, R. B., Schubert, P., Rothe, G., Gehrmann, J., Rudolphi, K. A., Valet, G., & Kreutzberg, G. W. (1994) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1994.19 · Cited by 104
Systemic LPS administration induces brain inflammation but not dopaminergic neuronal death in the substantia nigra
Jeong, H., Jou, I., & Joe, E.-H. (2010) · Experimental & Molecular Medicine · doi:10.3858/emm.2010.42.12.085 · Cited by 104
The more you have, the less you get: the functional role of inflammation on neuronal differentiation of endogenous and transplanted neural stem cells in the adult brain
Mathieu, P., Battista, D., Depino, A. M., Roca, V., Graciarena, M., & Pitossi, F. J. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06548.x · Cited by 113
Peripheral blood inflammatory markers in early Parkinson’s disease
Kim, R., Kim, H., Kim, A., Jang, M., Kim, A., Kim, Y. H., Yoo, D., Im, J. H., Choi, J.-H., & Jeon, B. (2018) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2018.10.079 · Cited by 103
Alterations of the gut microbiota with antibiotics protects dopamine neuron loss and improve motor deficits in a pharmacological rodent model of Parkinson's disease
Koutzoumis, D. N., Vergara, M., Pino, J. A., Buddendorff, J., Khoshbouei, H., Mandel, R. J., & Torres, G. E. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.113159 · Cited by 103
Exploring the journey of emodin as a potential neuroprotective agent: Novel therapeutic insights with molecular mechanism of action
Mitra, S., Anjum, J., Muni, M., Das, R. C., Rauf, A., Islam, F., Emran, T. B., Semwal, P., Hemeg, H. A., Alhumaydhi, F. A., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112877 · Cited by 106
Transcriptional Factor NF- κ B as a Target for Therapy in Parkinson's Disease
Flood, P. M., Li, Q., Peterson, L. J., Zhang, F., Shi, J., Gao, H., & Hong, J. (2011) · Parkinson s Disease · doi:10.4061/2011/216298 · Cited by 104
LPS-induced release of IL-6 from glia modulates production of IL-1β in a JAK2-dependent manner
Minogue, A. M., Barrett, J. P., & Lynch, M. A. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-126 · Cited by 104
PET Neuroimaging of Alzheimer's Disease: Radiotracers and Their Utility in Clinical Research
Bao, W., Xie, F., Zuo, C., Guan, Y., & Huang, Y. H. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.624330 · Cited by 102
Paroxetine ameliorates lipopolysaccharide-induced microglia activation via differential regulation of MAPK signaling
Liu, R., Zou, M., Wang, J., Zhu, J., Lai, J.-M., Zhou, L.-L., Chen, S., Zhang, X., & Zhu, J. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-47 · Cited by 100
Mitochondria-Derived Damage-Associated Molecular Patterns in Neurodegeneration
Wilkins, H. M., Weidling, I. W., Ji, Y., & Swerdlow, R. H. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00508 · Cited by 102
Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson’s disease
Eidson, L. N., Kannarkat, G. T., Barnum, C. J., Chang, J., Chung, J., Caspell‐Garcia, C., Taylor, P., Mollenhauer, B., Schlossmacher, M. G., Ereshefsky, L., et al. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0935-1 · Cited by 102
Silencing Alpha Synuclein in Mature Nigral Neurons Results in Rapid Neuroinflammation and Subsequent Toxicity
Benskey, M. J., Sellnow, R. C., Sandoval, I. M., Sortwell, C. E., Lipton, J. W., & Manfredsson, F. P. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00036 · Cited by 102
Innate Immunity: A Common Denominator between Neurodegenerative and Neuropsychiatric Diseases
Novellino, F., Saccà, V., Donato, A., Zaffino, P., Spadea, M. F., Vismara, M. F. M., Arcidiacono, B., Malara, N., Presta, I., & Donato, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031115 · Cited by 107
Transcriptional profile of Parkinson blood mononuclear cells with LRRK2 mutation
Mutez, E., Larvor, L., Leprêtre, F., Mouroux, V., Hamalek, D., Kerckaert, J., Pérez‐Tur, J., Waucquier, N., Vanbesien-Mailliot, C., Duflot, A., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.10.016 · Cited by 109
Brain β2-microglobulin levels are elevated in the striatum in Parkinson's diseaselevels are elevated in the striatum in Parkinson's disease
Mogi, M., Harada, M., Kondo, T., Riederer, P. F., & Nagatsu, T. (1995) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02252965 · Cited by 104
Genetic and Transcriptomic Profiles of Inflammation in Neurodegenerative Diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and Tauopathies
López González, I., Garcia-Esparcia, P., Llorens, F., & Ferrer, I. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020206 · Cited by 101
TREM2 deficiency aggravates α‐synuclein–induced neurodegeneration and neuroinflammation in Parkinson's disease models
Guo, Y., Wei, X., Yan, H., Qin, Y., Yan, S., Liu, J., Zhao, Y., Jiang, F., & Lou, H. (2019) · The FASEB Journal · doi:10.1096/fj.201900992r · Cited by 101
Chronic restraint stress triggers dopaminergic and noradrenergic neurodegeneration: Possible role of chronic stress in the onset of Parkinson’s disease
Sugama, S., Sekiyama, K., Kodama, T., Takamatsu, Y., Takenouchi, T., Hashimoto, M., Conti, B., & Kakinuma, Y. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.08.015 · Cited by 106
Brain-resident microglia predominate over infiltrating myeloid cells in activation, phagocytosis and interaction with T-lymphocytes in the MPTP mouse model of Parkinson disease
Depboylu, C., Stricker, S., Ghobril, J.-P., Oertel, W. H., Priller, J., & Höglinger, G. U. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.08.020 · Cited by 104

Authors: McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G.
Affiliations: University of British Columbia (CA)
ORCID: McGeer, P. L.
Boyes, B. E.
Venue: Neurology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 1988-08
Volume: 38
Issue: 8
Pages: 1285-1285
ISSN: 0028-3878 (ISSN-L)
1526-632X
DOI: 10.1212/wnl.38.8.1285
OpenAlex: W1974924674
Cited by: 2,990
References: 0
Citations by year: 2026: 98 · 2025: 130 · 2024: 148 · 2023: 148 · 2022: 175 · 2021: 159 · 2020: 159 · 2019: 129 · 2018: 131 · 2017: 93 · 2016: 108 · 2015: 111 · 2014: 120 · 2013: 116 · 2012: 127
FWCI: 10.67
Type: journal article
Language: en
Open access: closed
Locations: Neurology (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords: reactive microglia, HLA-DR, substantia nigra, Parkinson's disease, Alzheimer's disease, Lewy bodies, melanin, amyloid plaques, neurofibrillary tangles, choline acetyltransferase, hippocampus
MeSH terms: Aged, Aged, 80 and over, Alzheimer Disease, Brain Chemistry, Dementia, Female, HLA-D Antigens, HLA-DR Antigens, Humans, Male, Melanins, Middle Aged, Neuroglia, Parkinson Disease, Substantia Nigra

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks